BOSTON (AP) — A New Jersey pharmaceuticals firm will pay nearly $25 million in criminal and civil fines after pleading guilty to federal charges that it made illegal payments to encourage doctors to prescribe a blood pressure drug. The U.S. attorney's office in Boston announced Monday that Massachusetts-based Biovail Pharmaceuticals Inc. was sentenced to pay $22.2 million after pleading guilty to conspiracy and kickback charges. The company also will pay a $2.4 million civil penalty. Prosecutors alleged Biovail paid thousands of physicians and others up to $1,000 apiece to induce them to prescribe or recommend Cardizem LA. The company is a subsidiary of Toronto-based Biovail Corp., which announced in May 2008 it had agreed to plead guilty and pay to settle the case.